Making deals with evolving technologies in mind
In today's business environment, companies must consider and understand h...Johnson Controls deals for asset-tracking software
The Milwaukee-based Johnson Controls, which provides systems, technology, and services to buildings - inclu...Democracy and the Net - How American ideals are quietly influencing the world
Perhaps that explains why some global web-o-crats are forever working to wrest maintenan...Arbitration can help when IT deals go sour
Two companies enter into an agreement to develop software, implement software, develop a new Web site, or have a service provider deliver a range of services in the information technology area. Often these contracts work out perfectly well and the parties come to the end of the engagement reasonably satisfied wit...Money Tree survey shows lull in Wisconsin venture capital deals
Wisconsin didn't produce a single venture capital deal from January through March this year, according to the recently published Money Tree survey. Venture capitalists in the state said that the lack of deals in a quarter is not necessarily representative of the state, though it is another reminder that capital is hard to come by. For the past four years, Wisconsin's investments...Rip Off: Care Less about Medicare $90m Fraud Deals?
This is organized crime that is on the brink of milking Medicare. Australian Medicare cards are being used by foreigners to avail free medical treatment, according to News Ltd newspapers’, announcement today. These phony deals have cost a mammoth $90 million dollar a year, according to agency reports.// The agency has reported a case of a Victorian, recently in the docks for permitting...Experimental Drug Deals Effectively with Prostate Cancer Cells
An experimental RNA-based drug acts by using genetic material called targeting RNA, to enter cancer cells, and another type, called silencing RNA// , to stop the expression of a protein that keeps the cells alive, thereby destroying prostate cancer cells leaving normal cells unharmed. The drug, developed at Duke University Medical Center, uses one type of genetic material, cal...